Norprolac · DIN 02223775 · 0.15 mg · tablet
Limited Use, Reason for Use code 405 required; Health Canada lists this DIN as Cancelled post market since 2021-06-02 — choose a marketed DIN from the same-category list.Discontinued June 2, 2021 · checked November 17, 2026
StatusLimited Use, Reason for Use code 405 required; Health Canada lists this DIN as Cancelled post market since 2021-06-02 — choose a marketed DIN from the same-category list.
Write on scriptReason for Use code 405 (criteria below); Health Canada lists this DIN as Cancelled post market since 2021-06-02 — choose a marketed DIN from the same-category list.
Patient paysIf the Reason for Use code is written and the criteria are met, ODB 65 and over pays:
• ODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
• Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
If the criteria are not met, ODB does not pay this product under Limited Use. [Limited Use benefit, Formulary flag]
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 405
Reason for Use code 405
For the treatment of hyperprolactinemia in patients who have:
* Failed to respond to a greater than or equal to 3 month trial of bromocriptine; or
* Failed to tolerate bromocriptine; or
* Failed to shrink a prolactinoma by greater than 1 cm after 12 months of bromocriptine therapy
Coverage limit:
LU Authorization Period: 5 years.
No interchangeable product listed in the Ontario extract
Norprolac · DIN 02223775
Manufacturer: Ferring Inc.; listing date 2006-10-23
Health Canada: Cancelled post market since 2021-06-02 · brand NORPROLAC · ATC G02CB04 QUINAGOLIDE · form Tablet · route Oral · ingredients QUINAGOLIDE (QUINAGOLIDE HYDROCHLORIDE) 0.15 MG · company Ferring inc · schedule Prescription
Norprolac: Formulary list price $1.73 per unit (the source does not state the unit; exact figure $1.7294). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02223775)
Source record
DIN 02223775: Norprolac
Raw flags: sec12=Y, sec3=Y
Item: 920000542; group id 950; item number 2257; lccId 00197; manufacturer id FEI
Source form: Tab; strength: 0.15mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below
Source prices (unrounded): $1.7294; ministry $1.7294
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02223775
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=43392
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since June 2, 2021 — choose a marketed DIN from the same-category list.